Wendy Bockelman
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,244, more than ten times the $74 reported in 2022.
Across 70 payments — averaging $27.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$281
- AbbVie$235
- AstraZeneca$165
- Exact Sciences$162
- Corcept Therapeutics$141
- Gilead$125
- plus $782 from 18 others
What the payments were for
- Food & beverage$1,890100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 9 | $281 |
| AbbVie | 11 | $235 |
| AstraZeneca | 3 | $165 |
| Exact Sciences | 5 | $162 |
| Corcept Therapeutics | 5 | $141 |
| Gilead | 1 | $125 |
| Inspire Medical Systems, Inc. | 1 | $119 |
| Novo Nordisk | 4 | $95 |
| Tris Pharma Inc | 4 | $95 |
| Antares Pharma, Inc. | 5 | $78 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $48 |
| Dexcom, Inc. | 3 | $43 |
| Boehringer Ingelheim | 2 | $43 |
| Pfizer | 2 | $39 |
| Astellas Pharma US Inc | 2 | $36 |
| Noven Therapeutics, LLC | 2 | $36 |
| Si-bone, Inc. | 1 | $28 |
| Medtronic | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Tolmar, Inc. | 1 | $19 |
| Amgen | 1 | $17 |
| IBSA Pharma Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $14 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,890 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 11 | $99 |
Paid to pharmacies, not to this prescriber.
Other family in Plano
- Kori NelsonPlano$148K
- Zaineb ShamsPlano$64K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.